Cargando…
Serum levels of ACE2 are higher in patients with obesity and diabetes
OBJECTIVE: As severity of outcome in COVID‐19 is disproportionately higher among individuals with obesity, smokers, patients with hypertension, kidney disease, chronic pulmonary disease, coronary heart disease (CHD), and/or type 2 diabetes (T2D), serum levels of ACE2, the cellular entry point for th...
Autores principales: | Emilsson, Valur, Gudmundsson, Elias F., Aspelund, Thor, Jonsson, Brynjolfur G., Gudjonsson, Alexander, Launer, Lenore J., Lamb, John R., Gudmundsdottir, Valborg, Jennings, Lori L., Gudnason, Vilmundur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019273/ https://www.ncbi.nlm.nih.gov/pubmed/33841894 http://dx.doi.org/10.1002/osp4.472 |
Ejemplares similares
-
Antihypertensive medication uses and serum ACE2 levels: ACEIs/ARBs treatment does not raise serum levels of ACE2
por: Emilsson, Valur, et al.
Publicado: (2020) -
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
por: Emilsson, Valur, et al.
Publicado: (2020) -
A genome-wide association study of serum proteins reveals shared loci with common diseases
por: Gudjonsson, Alexander, et al.
Publicado: (2022) -
Coding and regulatory variants are associated with serum protein levels and disease
por: Emilsson, Valur, et al.
Publicado: (2022) -
Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes
por: Gudmundsdottir, Valborg, et al.
Publicado: (2020)